Welcome to Valicare!
-
GMP consulting and compliance is one of our strengths. Whether GAP analyses, conceptual design, updating or implementation of a GMP system our GMP experts support you competently and efficiently.
Learn more -
Visit our exhibition booth no.3 at the German Biotechnology Days in Stuttgart from 20-21.09.2021
Learn more
Events
Nachrichten aus aller Welt
Unser internationaler Pressespiegel zeigt eine Auswahl an Nachrichten und neusten Artikel zu den Themen Arzneimittel neuartiger Therapien (ATMP), Chimäre Antigenrezeptor(CAR)-T-Zell-Therapie, Tumor infiltrierende Lymphozyten (TIL) und biotechnologisch bearbeitete Gewebeprodukte (TEP).
FDA Updates for the Week of October 11, 2021
16.10.2021 | Managed Healthcare ExecutiveIn COVID-19 news: An advisory committee recommends both J&J's and Moderna’s booster, Regeneron seeks full approved for its treatment and ...
New strides in H2O2 biodecontamination
15.10.2021 | Cleanroom TechnologySince the emergence of ‘isolator technology’ in the 1980s, hydrogen peroxide has been the favoured agent for biodecontamination because the ...
EMA starts rolling review of AstraZeneca antibody cocktail to prevent COVID-19
14.10.2021 | FirstWord PharmaHomePartner Showcase Register Free Trial Contact Us Advertise My NewsMy CompanyWatch My ConditionWatch My ...
Friday Five – The Pharma Week in Review (15 October 2021)
14.10.2021 | FirstWord PharmaHomePartner Showcase Register Free Trial Contact Us Advertise My NewsMy CompanyWatch My ConditionWatch My ...
Adoptive T-cell immunotherapy in digestive tract malignancies: Current challenges and future perspectives
14.10.2021 | Science DirectHighlights • Tumor-infiltrating lymphocytes (TILs), T cell receptor (TCR)-redirected T cells and chimeric antigen receptor (CAR)-engineered ...
New CAR T-Cell Therapy Appears Safe in B-Cell Malignancies
13.10.2021 | Targeted OncologyCTX100, an allogeneic chimeric antigen receptor (CAR) T-cell therapy for the treatment of relapsed or refractory CD19-positive B-cell ...
Thinking About Risk Early on Is Key for Cell Therapy Success
13.10.2021 | Labiotech.eu
NeoImmuneTech Announces First Patient Dosed in Phase 1b Study of NT-I7 (efineptakin alfa) and Kymriah® (tisagenlecleucel) in Relapsed/Refractory Large B-Cell Lymphoma
13.10.2021 | Le Lezard (EN)
The Benefit of CAR T-Cell Therapy in Indolent Lymphoma
12.10.2021 | Oncology - CancerNetworkCaron A. Jacobson, MD, MMSC, highlights data supporting the use of CAR T-cell therapy in patients with indolent lymphoma.
A New Line of Defense in Blood Cancer: Natural Killer Cell Therapy
11.10.2021 | CUREBob Schulz knew something was wrong when he had a hard time walking up the hill while golfing in December 2018. At 73, he still walked the ...
US FDA approves Enzyvant’s Rethymic, a one-time regenerative tissue-based therapy for pediatric congenital athymia
11.10.2021 | Pharmabiz.comEnzyvant announced the US Food and Drug Administration (FDA) approval of Rethymic (allogeneic processed thymus tissue-agdc), a one-time ...
Alternative zu ELISA: Echtzeitanalyse von Protein-Protein Interaktionen
10.10.2021 | LaborPraxis - Vogel Business Media
COVID-19 research news in brief
10.10.2021 | Insight PlusFrom the New England Journal of MedicineEffectiveness of mRNA COVID-19 vaccine among US health care personnel: “The ...
FDA Updates for the Week of Oct. 4, 2021
09.10.2021 | Managed Healthcare ExecutivePfizer officially seeks EUA for pediatric COVID vaccine, AstraZeneca seeks EU for COVID-19 prevention, J&J submits data for COVID-19 ...
Nerve repair, with help from stem cells
09.10.2021 | Biz News PostFaced with repairing a major nerve injury to the face or mouth, skilled surgeons can take a nerve from an arm or leg and use to it restore ...
Valicare – competent, reliable & efficient
You have little time and still want to know what services Valicare GmbH offers?